Generic name: Azilsartan kamedoxomil 40mg, chlorthalidone 12.5mg
Dosage form: tablet
Medically reviewed by Drugs.com. Last updated on Jun 5, 2020.
The recommended starting dose of Edarbyclor is 40/12.5 mg taken orally once daily. Most of the antihypertensive effect is apparent within 1 to 2 weeks. The dosage may be increased to 40/25 mg after 2 to 4 weeks as needed to achieve blood pressure goals. Edarbyclor doses above 40/25 mg are probably not useful.
Patients titrated to the individual components (azilsartan medoxomil and chlorthalidone) may instead receive the corresponding dose of Edarbyclor.
Edarbyclor may be administered with other antihypertensive agents as needed.
Prior to Dosing
Correct any volume depletion prior to administration of Edarbyclor, particularly in patients with impaired renal function or those treated with high doses of diuretics [see Warnings and Precautions (5.2)].
Patients who experience dose-limiting adverse reactions on chlorthalidone may be switched to Edarbyclor, initially with a lower dose of chlorthalidone [see Warnings and Precautions (5.4)].
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Edarbyclor (azilsartan medoxomil / chlorthalidone)
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 18 Reviews
- Drug class: angiotensin II inhibitors with thiazides
- FDA Approval History